{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:10:08Z","timestamp":1793387408379,"version":"4.5.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2018,11,2]]},"DOI":"10.1080\/14737167.2018.1512408","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T15:13:00Z","timestamp":1535123580000},"page":"609-617","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Adherence and resource use among psoriasis patients treated with biologics"],"prefix":"10.1080","volume":"18","author":[{"given":"Joseph S.","family":"Aleshaki","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah A.","family":"Cardwell","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mik\u00e9l E.","family":"Muse","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-6289","authenticated-orcid":false,"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[{"name":",","place":["USA"]},{"name":",","place":["USA"]},{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15531"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.049"},{"key":"e_1_3_3_6_1","unstructured":"World Health Organization \u2013 Adherence to long-term therapies: evidence for action. World Health Organization WHO [Internet]. 2015 [cited 2017 Oct 23]. Available from: http:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_report\/en\/"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12039"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14178"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15856"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12294"},{"issue":"10","key":"e_1_3_3_11_1","first-page":"1090","article-title":"Adherence to ustekinumab in psoriasis patients","volume":"12","author":"Sandoval LF","year":"2013","unstructured":"Sandoval LF, Huang KE, Feldman SR. Adherence to ustekinumab in psoriasis patients. JDD. 2013;12(10):1090\u20131092.","journal-title":"JDD"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S26314"},{"issue":"5","key":"e_1_3_3_13_1","doi-asserted-by":"crossref","first-page":"18182","DOI":"10.5070\/D3195018182","article-title":"Adherence to adalimumab in patients with moderate to severe psoriasis","volume":"19","author":"West C","year":"2013","unstructured":"West C, Narahari S, O\u2019Neill J, et al. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. 2013;19(5):18182.","journal-title":"Dermatol Online J"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000444581"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/2325957414557263"},{"issue":"7","key":"e_1_3_3_16_1","first-page":"848","article-title":"A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies","volume":"13","author":"Levin AA","year":"2014","unstructured":"Levin AA, Gottlieb AB, Au SC. A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies. JDD. 2014;13(7):848\u2013853.","journal-title":"JDD"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.048"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.296"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14504"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.1271"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S85773"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13860"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S117006"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2011"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1485"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12862"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129120"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903185557"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150540"},{"issue":"2","key":"e_1_3_3_30_1","first-page":"147","article-title":"Lower socioeconomic status is associated with decreased therapeutic response to the biologic agents in psoriasis patients","volume":"15","author":"Sorensen EP","year":"2016","unstructured":"Sorensen EP, Algzlan H, Au SC, et al. Lower socioeconomic status is associated with decreased therapeutic response to the biologic agents in psoriasis patients. JDD. 2016;15(2):147\u2013153.","journal-title":"JDD"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09944.x"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.22.4.396"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0194-4"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.5070\/D30WZ4H31B"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212266"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15756"},{"issue":"1","key":"e_1_3_3_37_1","first-page":"24","article-title":"Innovation and competition: will biosimilars succeed? The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety","volume":"9","author":"Blackstone EA","year":"2012","unstructured":"Blackstone EA, Fuhr JP Jr. Innovation and competition: will biosimilars succeed? The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety. Biotechnol Healthc. 2012;9(1):24\u201327.","journal-title":"Biotechnol Healthc"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.12.014"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1054782"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2018.1512408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:35:09Z","timestamp":1772703309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2018.1512408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11,2]]}},"alternative-id":["10.1080\/14737167.2018.1512408"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2018.1512408","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}